For the Inventor, By the Inventor

Enter inventor name

Giangiacomo Torri

USPTO Granted Patents = 28 (Patent Applications = 1)

CIPO Patents = 3

EPO Patents = 6 (Patent Applications = 5)

Average Co-Inventor Count = 3.7

ph-index = 9

Forward Citations = 182(Granted Patents)

Company Filing History:

Novahealth Biosystems, LLC

Massachusetts Institute of Technology

Crinos Industria Farmacobiologica S.p.a.

Istituto Di Ricerche Chimiche E Biochimiche G Ronzoni

5. 2 out of 343

Sigma-tau Industrie Farmaceutiche Riunite S.p.a.

Sigma-tau Research Switzerland S.a.

7. 2 out of 2,480

Baxter International Inc.

8. 1 out of 17,164

The Procter Gamble Company

10. 1 out of 17

Grace Italiana S.p.a.

12. 1 out of 106

Instituto Di Ricerche Chimiche E Biochimiche G. Ronzoni

Next Technology Tecnotessile Societa Nazionale Di Ricerca R.l.

Instuto Scientifico Di Chimica E Biochimica “G. Rozoni”

Edmond Pharma, S.r.l.

Laboratori Derivati Organici Spa

18. 1 out of 832,680

Other

patents

where one patent can have more than one assignee

Years Active: 1984-2022

Loading Chart...

Loading Chart...

Loading Chart...

28 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11370848 - Carboxylated derivatives of glycosaminoglycans and use as drugs (2022-06-28),

2. 11332548 - Carboxylated derivatives of glycosaminoglycans and use as drugs (2022-05-17),

3. 11248063 - Derivatives of N-desulfated glycosaminoglycans and use as drugs (2022-02-15),

4. 10875936 - Derivatives of N-desulfated glycosaminoglycans and use as drugs (2020-12-29),

5. 10822430 - Carboxylated derivatives of glycosaminoglycans and use as drugs (2020-11-03),

6. 8853387 - Mimetics of sulfated oligosaccharides (2014-10-07),

7. 8222231 - Derivatives of partially desulphated glycosaminoglycans endowed with antiangiogenic activity and devoid of anticoagulating effect (2012-07-17),

8. 8067555 - Derivatives of partially desulphated glycosaminoglycans as heparanase inhibitors, endowed with antiangiogenic activity and devoid of anticoagulating effect (2011-11-29),

9. 8018231 - Method for sequence determination using NMR (2011-09-13),

10. 7939512 - Multistep process for the physical depolymerization of heparin and products obtained therefrom (2011-05-10),

11. 7790700 - Derivatives of partially desulphated glycosaminoglycans endowed with antiangiogenic activity and devoid of anticoagulating effect (2010-09-07),

12. 7781416 - Derivatives of partially desulphated glycosaminoglycans as heparanase inhibitors, endowed with antiangiogenic activity and devoid of anticoagulating effect (2010-08-24),

13. 7754878 - Free-radical functionalized polysaccharides (2010-07-13),

14. 7737692 - Method for sequence determination using NMR (2010-06-15),

15. 7728589 - Method for sequence determination using NMR (2010-06-01),

Title: Giangiacomo Torri - Pioneering Inventor from Milan

Introduction: Giangiacomo Torri is a renowned inventor hailing from Milan, Italy, known for his groundbreaking contributions to various fields through his innovative creations.

Latest Patents: Giangiacomo Torri holds several patents in the areas of renewable energy technologies, sustainable materials, and advanced robotics, showcasing his commitment to developing solutions for the future.

Career Highlights: Throughout his illustrious career, Torri has received numerous accolades for his inventive spirit and has been recognized for his ability to transform complex ideas into practical applications that benefit society.

Collaborations: Torri has collaborated with leading research institutions, universities, and tech companies worldwide to further his inventions and bring them to the market, solidifying his reputation as a visionary inventor.

Conclusion: Giangiacomo Torri's passion for innovation and his relentless pursuit of excellence have established him as a trailblazer in the world of inventions, inspiring the next generation of inventors to push the boundaries of what is possible.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Loading…